Evidence map›Paper›PMID 41280832›Full record

ArticleACS omega2025

Prediction of Permeability and Efflux Using Multitask Learning.

Philip Ivers Ohlsson, Gian Marco Ghiandoni, Susanne Winiwarter, Rocío Mercado, Vigneshwari Subramanian

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philip Ivers OhlssonDepartment of Computer Science and Engineering, Chalmers University of Technology and University of Gothenburg, Chalmersplatsen 1, 412 96 Gothenburg, Sweden.
Gian Marco GhiandoniAugmented DMTA Platform, Data Analytics and AI, The Discovery Centre (DISC), R&D IT, AstraZeneca, Francis Crick Avenue, Cambridge CB2 0AA, U.K.ORCID https://orcid.org/0000-0002-2592-2939
Susanne WiniwarterDrug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal 431 83, Sweden.ORCID https://orcid.org/0000-0002-9808-1683
Rocío MercadoDepartment of Computer Science and Engineering, Chalmers University of Technology and University of Gothenburg, Chalmersplatsen 1, 412 96 Gothenburg, Sweden.
Vigneshwari SubramanianChemical Toxicology, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.ORCID https://orcid.org/0000-0002-7319-8885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41280832
PMCPMC12631307

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.